Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Quality Of Life Better With Both CABG And PCI

October 16, 2013 By Todd Neale

Both coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) with drug-eluting stents resulted in dramatic improvements in quality of life among diabetic patients with multivessel disease, a subanalysis of the FREEDOM trial showed.

Although improvements were more rapid in the PCI group, and slightly better through the first 2 years in the CABG group, health status was mostly similar in the two groups in the long term, David Cohen, MD, of Saint Luke’s Mid American Heart Institute in Kansas City, Mo., and colleagues reported in the Oct. 16 issue of the Journal of the American Medical Association.

The small differences in quality of life contrasted with the substantial difference in the 5-year rate of death, stroke, or myocardial infarction (MI) seen in the main trial results — 26.6% with PCI versus 18.7% with CABG (P=0.005). CABG lowered the rates of death and MI, but increased the rate of stroke.

The quality-of-life differences were smaller than expected because many patients who were treated initially with PCI required a repeat revascularization procedure (12.6% versus 4.8% in the CABG group through 1 year) and many underwent CABG for the second procedure, according to co-author Valentin Fuster, MD, PhD, of Mount Sinai Medical Center in New York City, who led the FREEDOM trial.

Fuster told MedPage Today that the main message from FREEDOM remains clear: “There are always exceptions, but the exception should not overcome the reality of this trial, and that is that about 25% of patients that today we see in the cardiac catheterization laboratory have multivessel disease with diabetes and they should be considered after the angiogram for bypass surgery, not for PCI.”

In their paper, Cohen, Fuster, and colleagues pointed out that there still might be a role for PCI for some patients.

“Given the increased rate of stroke, as well as the well-recognized longer recovery period with CABG surgery, … some patients who do not wish to face these acute risks may still choose the less invasive PCI strategy,” they wrote. “For such patients, our study provides reassurance that there are not major differences in long-term health status and quality of life between the two treatment strategies.”

Continue reading…

Related Articles Read More >

Avail Medsystems
How Avail Medsystems seeks to create a connected OR experience
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
FDA logo
FDA seeking innovations to move beyond heater-cooler device problems
Logos of Creo Medical and Intuitive
Creo Medical inks collaboration agreement with Intuitive

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech